Walleye Capital LLC Reata Pharmaceuticals Inc Transaction History

Walleye Capital LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	SELL	$79.22 - $105.37 $964,820 - $1.28 Million	-12,179 Reduced 86.36%	1,923 $196,000
Q1 2023 May 15, 2023	BUY	$30.85 - $93.17 $435,046 - $1.31 Million	14,102 New	14,102 $1.28 Million
Q3 2022 Nov 14, 2022	BUY	$19.41 - $36.49 $396,216 - $744,870	20,413 New	20,413 $513,000
Q1 2022 May 16, 2022	SELL	$24.12 - $39.6 $1.23 Million - $2.02 Million	-51,036 Closed	0 $0
Q4 2021 Mar 03, 2022	BUY	$25.61 - $110.96 $1.31 Million - $5.66 Million	51,036 New	51,036 $1.35 Million
Q4 2019 Feb 14, 2020	SELL	$74.57 - $217.92 $577,768 - $1.69 Million	-7,748 Closed	0 $0
Q3 2019 Nov 14, 2019	BUY	$71.26 - $95.75 $552,122 - $741,871	7,748 New	7,748 $622,000

62.7K

Ticker RETA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 31,583,200
Description
Reata Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, identifies, develops, and commercializes novel therapeutics for patients with serious or life-threatening diseases. The company is developing Phase 3 clinical trial programs, including bardoxolone methyl (bardoxolone) for the treatment of patients with chronic kidney diseas...

Get notified when there are updates to the investment portfolio of Walleye Capital LLC, based on Form 13F filings with the SEC.

Stay updated on Walleye Capital LLC with notifications on news.